This product line is based on a proprietary platform technology which has enabled the creation of a series of immortalized hypothalamic neurons; immortalized from rat embryonic day 18 hypothalamic primary cultures by retroviral transfer of SV40 T-Ag. These cell lines have been found to express an ever expanding array of neuropeptides, enzymatic markers and biologically […]
This product line is based on a proprietary platform technology which has enabled the creation of a series of immortalized hypothalamic neurons; immortalized from rat embryonic day 18 hypothalamic primary cultures by retroviral transfer of SV40 T-Ag. These cell lines have been found to express an ever expanding array of neuropeptides, enzymatic markers and biologically active receptors.
As such, these cell lines enable accurate in-vitro assays for use in the discovery, development and validation of new therapeutics targeted to central-nervous system diseases and disorders, including obesity, stress, and metabolic disorders, amongst others.
| Product | Units |
|---|---|
|
(rHypoE-11) CLU205 |
1 Ml |
|
(rHypoE-13) CLU206 |
1 Ml |
|
(rHypoE-15) CLU207 |
1 Ml |
|
(rHypoE-16) CLU208 |
1 Ml |
|
(rHypoE-18) CLU209 |
1 Ml |
|
(rHypoE-19) CLU210 |
1 Ml |
|
(rHypoE-20) CLU211 |
1 Ml |
|
(rHypoE-21) CLU212 |
1 Ml |
|
(rHypoE-22) CLU213 |
1 Ml |
|
(rHypoE-23) CLU214 |
1 Ml |
|
(rHypoE-24) CLU215 |
1 Ml |
|
(rHypoE-25) CLU216 |
1 Ml |
|
(rHypoE-27) CLU217 |
1 Ml |
|
(rHypoE-28) CLU218 |
1 Ml |
|
(rHypoE-29) CLU219 |
1 Ml |
|
(rHypoE-30) CLU220 |
1 Ml |
|
(rHypoE-31) CLU221 |
1 Ml |
|
(rHypoE-33) CLU222 |
1 Ml |
|
(rHypoE-6) CLU201 |
1 Ml |
|
(rHypoE-7) CLU202 |
1 Ml |
|
(rHypoE-8) CLU203 |
1 Ml |
|
(rHypoE-9) CLU204 |
1 Ml |
We work with a range of suppliers with novel and innovative products sourced from our global partners.
Find Products